Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
Completed · Phase 4
Conditions studied: Cataract
In brief
The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.
Key facts
- Study ID
- NCT01248572
- Run by
- Lenstec Incorporated
- People needed
- 40
- Starts
- 2010-10-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2014-03-18
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- >=40 years of age, of any race and either gender
- Operable, age related cataract grade 3+ or lower in the study eye
- Able to achieve best corrected visual acuity (BCVA) 20/30 Snellen or better postoperatively in the study eye
- ≤1.0 diopter (D) of corneal astigmatism preoperatively in the study eye
- Able to achieve a dilated pupil >6.0 millimeter (mm) in the study eye
- Able to adequately visualize the lens equatorial diameter on ultrasound biomicroscopy (UBM) unit (preoperatively)
- Desire implantation of a monofocal lenses targeted at emmetropia in the study eye
- In good general and ocular health
- Able to competently complete testing
- Willing and able to attend study visits
- Willing and able to understand and sign an informed consent
You may not qualify if…
- Previous intraocular surgery or laser treatment
- Severe dry eye
- Uncontrolled IOP or glaucoma
- Retinal or macular pathology (i.e. macular degeneration, proliferative diabetic retinopathy, etc.)
- History of retinal detachment
- Microphthalmia
- Chronic severe uveitis
- Corneal decompensation
- Irregular astigmatism
- History of corneal disease (e.g., herpes simplex, herpes zoster keratitis, etc.)
- Clinically significant corneal endothelial dystrophy (e.g., Fuchs' dystrophy)
- Pseudoexfoliation syndrome
- Iris atrophy
- Pupil abnormalities (e.g., corectopia)
- Aniseikonia
- Amblyopia
- An acute or chronic disease or illness that may confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness)
- Pregnant, lactating, or planning to become pregnant during the course of the trial
- Participation in another clinical trial within 30 days of study start
Where it is running
- Barnet-Dulaney-Perkins Eye Center — Phoenix, Arizona, United States
- Eye Centers of Florida — Fort Myers, Florida, United States
- Harbin Clinic — Rome, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.